Poór M - Search Results

1

In vitro testing of host-targeting small molecule antiviral matriptase/TMPRSS2 inhibitors in 2D and 3D cell-based assays.

van Eijk N, Schmacke LC, Steinmetzer T, Pilgram O, Poór M, Pászti-Gere E. van Eijk N, et al. Among authors: poor m. Biomed Pharmacother. 2023 Dec;168:115761. doi: 10.1016/j.biopha.2023.115761. Epub 2023 Oct 20. Biomed Pharmacother. 2023. PMID: 37865989 Free article.

2

Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormone.

Becker GW, Bowsher RR, Mackellar WC, Poor ML, Tackitt PM, Riggin RM. Becker GW, et al. Among authors: poor ml. Biotechnol Appl Biochem. 1987 Dec;9(6):478-87. doi: 10.1111/j.1470-8744.1987.tb00491.x. Biotechnol Appl Biochem. 1987. PMID: 3440058

3

Visualization of multiple protein bands on the same nitrocellulose membrane by double immunoblotting.

Poor ML, Santa PF, Sittampalam GS. Poor ML, et al. Anal Biochem. 1988 Nov 15;175(1):191-5. doi: 10.1016/0003-2697(88)90377-6. Anal Biochem. 1988. PMID: 2469351

4

Further aspects of ochratoxin A-cation interactions: complex formation with zinc ions and a novel analytical application of ochratoxin A-magnesium interaction in the HPLC-FLD system.

Poór M, Kuzma M, Matisz G, Li Y, Perjési P, Kunsági-Máté S, Kőszegi T. Poór M, et al. Toxins (Basel). 2014 Apr 10;6(4):1295-307. doi: 10.3390/toxins6041295. Toxins (Basel). 2014. PMID: 24727553 Free PMC article.

5

Poór M, Zrínyi Z, Kőszegi T. Poór M, et al. Biomed Pharmacother. 2016 Oct;83:998-1005. doi: 10.1016/j.biopha.2016.08.009. Epub 2016 Aug 12. Biomed Pharmacother. 2016. PMID: 27522262

6

Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme.

Poór M, Boda G, Needs PW, Kroon PA, Lemli B, Bencsik T. Poór M, et al. Biomed Pharmacother. 2017 Apr;88:574-581. doi: 10.1016/j.biopha.2017.01.092. Epub 2017 Jan 27. Biomed Pharmacother. 2017. PMID: 28135601

7

Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin.

Poór M, Boda G, Mohos V, Kuzma M, Bálint M, Hetényi C, Bencsik T. Poór M, et al. Biomed Pharmacother. 2018 Jun;102:912-921. doi: 10.1016/j.biopha.2018.03.146. Epub 2018 Apr 5. Biomed Pharmacother. 2018. PMID: 29710546

8

Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.

Mohos V, Bencsik T, Boda G, Fliszár-Nyúl E, Lemli B, Kunsági-Máté S, Poór M. Mohos V, et al. Among authors: poor m. Biomed Pharmacother. 2018 Nov;107:777-784. doi: 10.1016/j.biopha.2018.08.068. Epub 2018 Aug 22. Biomed Pharmacother. 2018. PMID: 30142539

9

Inhibitory effects of polyphenols and their colonic metabolites on CYP2D6 enzyme using two different substrates.

Fliszár-Nyúl E, Mohos V, Csepregi R, Mladěnka P, Poór M. Fliszár-Nyúl E, et al. Among authors: poor m. Biomed Pharmacother. 2020 Nov;131:110732. doi: 10.1016/j.biopha.2020.110732. Epub 2020 Sep 14. Biomed Pharmacother. 2020. PMID: 32942157 Free article.

10

Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes.

Faisal Z, Mohos V, Fliszár-Nyúl E, Valentová K, Káňová K, Lemli B, Kunsági-Máté S, Poór M. Faisal Z, et al. Among authors: poor m. Biomed Pharmacother. 2021 Jun;138:111459. doi: 10.1016/j.biopha.2021.111459. Epub 2021 Mar 9. Biomed Pharmacother. 2021. PMID: 33706132 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters